Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TdT Antikörper (AA 1-100)

DNTT Reaktivität: Human ELISA, IHC (f), Coat Wirt: Maus Monoclonal unconjugated Recombinant Antibody
Produktnummer ABIN7126304
  • Target Alle TdT (DNTT) Antikörper anzeigen
    TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
    Antikörpertyp
    Recombinant Antibody
    Bindungsspezifität
    • 12
    • 8
    • 8
    • 7
    • 5
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-100
    Reaktivität
    • 80
    • 19
    • 18
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    Human
    Wirt
    • 66
    • 16
    Maus
    Klonalität
    • 62
    • 19
    • 1
    Monoklonal
    Konjugat
    • 44
    • 8
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser TdT Antikörper ist unkonjugiert
    Applikation
    • 48
    • 37
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (Formalin-fixed Sections) (IHC (f)), Coating (Coat)
    Spezifität
    Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant fragment (around aa1-100) of human DNTT protein (exact sequence is proprietary)
    Isotyp
    IgG1
    Top Product
    Discover our top product DNTT Primärantikörper
  • Applikationshinweise

    Known_Application: ELISA (Use Ab at 2-4 μg/mL for coating) (Order Ab without BSA), ,Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human thymus. Jurkat cells.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
    Andere Bezeichnung
    DNTT (DNTT Produkte)
    Hintergrund
    Deoxynucleotidyltransferase terminal, DNTT, Nucleosidetriphosphate DNA Deoxynucleotidylexotransferase, TDT, Terminal addition enzyme, Terminal deoxynucleotidyltransferase, Terminal deoxyribonucleotidyltransferase,TdT / DNA Nucleotidylexotransferase (Acute Lymphoblastic Leukemia Marker)
    Cellular localisation: Nucleus
    Molekulargewicht
    58kDa
    Gen-ID
    1791, 534206
    UniProt
    P04053
    Pathways
    DNA Reparatur
Sie sind hier:
Kundenservice